Semma Therapeutics was founded with the goal of transforming treatment of type 1 diabetes by enabling people with this disease to generate the insulin their body needs. In type 1 diabetes, the body does not produce insulin, which plays a critical role in getting glucose from the bloodstream into the cells of the body. Since the 1920s, injectable insulin has been the only treatment available for people with type 1 diabetes.